Shane Skinner has invested in biotech companies for almost 20 years and placed over $2.6 million in biotech stock trades in 2013. He has held various financial leadership positions over the past 17 years throughout the United States and Europe including Chief Financial Officer. Shane graduated from Pepperdine University with an MBA, York College with a bachelor's degree in accounting, and is a licensed CPA. He was a collegiate soccer and rugby player and still plays in recreational leagues in Seattle. He has a wife, son, and one on the way!
I have written 2 dutch books on value investing: "Aandelen selecteren als waardebelegger" and "Beleggen in bull- en bearmarkten". See bol.com (search for the titles). As a mathematician (Ph.D.) I am most interested in investment strategies with statistically favorable returns. In particular I invest in net-nets (20-30% average annual returns). I find companies with low Enterprise Value/Earnings before Tax and Interest (EV/EBIT) and strong balance sheets (20% average annual returns) also very interesting. Since such stocks are rare I invest globally. Send me a message with your email address to get example articles of my premium research on Seeking Alpha.
Investing forever. Ok not forever but I have been doing my own trading since age 19 when I used to get charged like 200 bucks each way. Full commission sucked!. I have had a good bit of success. I have also had enough failure to make me realize that success in the past is not guaranteed by any long shot and no indicator of future success by any means.
I have been in technology since I was nine. I have been working in the field officially since I was 18.
I mix fundamentals and technicals but like most of you my gut and intuition still play an important role in trading because to ignore that aspect is to think the herd does not matter and in many cases the herd matters more than either technical or fundamental aspects of a stock.